[Biological diagnosis of pheochromocytomas and paragangliomas]. 2009

Michèle d'Herbomez, and Nathalie Rouaix, and Catherine Bauters, and Jean-Louis Wémeau
Université de Lille II, F-59000 Lille, France. m-dherbomez@chru-lille.fr

Pheochromocytomas and/or paragangliomas are rare, heterogeneous tumors of the chromaffin cells. Thirty percent of the patients presented with these diseases in a hereditary context. The biological diagnosis relies on the identification of excessive secretion of the metanephrines which are more sensitive and specific than those of catecholamines The published recommendations give the opportunity to choose between the free metanephrines and the fractionated metanephrines in sera or urines. The concentrations of the free plasmatic metanephrines reflect the ongoing production of tumor. They are little sensitive to the renal failure. The assay of the vanillylmandelic acid should be dropped because of its inefficiency. The assay of the chromogranin A in serum should be used in association with those of metanephrines in the diagnosis but also in the follow-up. Its role still has to be precised.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008676 Metanephrine Product of epinephrine O-methylation. It is a commonly occurring, pharmacologically and physiologically inactive metabolite of epinephrine. Metadrenaline
D010235 Paraganglioma A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992) Paraganglioma, Gangliocytic,Paragangliomata,Gangliocytic Paraganglioma,Gangliocytic Paragangliomas,Paragangliomas,Paragangliomatas
D010673 Pheochromocytoma A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298) Pheochromocytoma, Extra-Adrenal,Extra-Adrenal Pheochromocytoma,Extra-Adrenal Pheochromocytomas,Pheochromocytoma, Extra Adrenal,Pheochromocytomas,Pheochromocytomas, Extra-Adrenal
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000310 Adrenal Gland Neoplasms Tumors or cancer of the ADRENAL GLANDS. Adrenal Cancer,Adrenal Gland Cancer,Adrenal Neoplasm,Cancer of the Adrenal Gland,Neoplasms, Adrenal Gland,Adrenal Cancers,Adrenal Gland Cancers,Adrenal Gland Neoplasm,Adrenal Neoplasms,Cancer, Adrenal,Cancer, Adrenal Gland,Cancers, Adrenal,Cancers, Adrenal Gland,Neoplasm, Adrenal,Neoplasm, Adrenal Gland,Neoplasms, Adrenal
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014642 Vanilmandelic Acid A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE. Methoxyhydroxymandelic Acid,4-Hydroxy-3-Methoxymandelic Acid,Vanillylmandelic Acid,4 Hydroxy 3 Methoxymandelic Acid,Acid, 4-Hydroxy-3-Methoxymandelic,Acid, Methoxyhydroxymandelic,Acid, Vanillylmandelic,Acid, Vanilmandelic

Related Publications

Michèle d'Herbomez, and Nathalie Rouaix, and Catherine Bauters, and Jean-Louis Wémeau
April 2010, Nature reviews. Endocrinology,
Michèle d'Herbomez, and Nathalie Rouaix, and Catherine Bauters, and Jean-Louis Wémeau
January 2001, Endocrine pathology,
Michèle d'Herbomez, and Nathalie Rouaix, and Catherine Bauters, and Jean-Louis Wémeau
November 2003, Annales d'endocrinologie,
Michèle d'Herbomez, and Nathalie Rouaix, and Catherine Bauters, and Jean-Louis Wémeau
August 2021, Current opinion in pediatrics,
Michèle d'Herbomez, and Nathalie Rouaix, and Catherine Bauters, and Jean-Louis Wémeau
December 2019, Endocrinology and metabolism clinics of North America,
Michèle d'Herbomez, and Nathalie Rouaix, and Catherine Bauters, and Jean-Louis Wémeau
January 2006, Nephrologie & therapeutique,
Michèle d'Herbomez, and Nathalie Rouaix, and Catherine Bauters, and Jean-Louis Wémeau
December 2006, Orphanet journal of rare diseases,
Michèle d'Herbomez, and Nathalie Rouaix, and Catherine Bauters, and Jean-Louis Wémeau
April 2014, Molecular and cellular endocrinology,
Michèle d'Herbomez, and Nathalie Rouaix, and Catherine Bauters, and Jean-Louis Wémeau
December 2010, Best practice & research. Clinical endocrinology & metabolism,
Michèle d'Herbomez, and Nathalie Rouaix, and Catherine Bauters, and Jean-Louis Wémeau
January 2012, Medecine sciences : M/S,
Copied contents to your clipboard!